These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2693541)

  • 1. [Clinical trial of T-3262 on acute enteritis. Japan Research Committee of T-3262, Research Group for Acute Infectious Enteritis].
    Aoki T; Matsubara Y; Sagara H; Tomizawa I; Takizawa Y; Nitta Y; Seo T; Kamimura M; Masuda G; Negishi M
    Kansenshogaku Zasshi; 1989 Jun; 63(6):593-605. PubMed ID: 2693541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical trial of T-3262 (Tosufloxacin tosilate) on Salmonella enteritis, and fecal drug concentration and change in the fecal microflora in the acute diarrheal patients. Japan Research Committee of T-3262, Research Group for Acute Infectious Enteritis].
    Aoki T; Matsubara Y; Sagara H; Shimizu N; Tomizawa I; Takizawa Y; Nitia Y; Seo T; Kamimura M; Kanehisa N
    Kansenshogaku Zasshi; 1989 Jul; 63(7):659-75. PubMed ID: 2693543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical study of prulifloxacin on infectious enteritis. Japan Research Committee of Prulifloxacin, Research Group on Infectious Enteritis].
    Tomizawa I; Takizawa Y; Nitta Y; Tsunoda T; Fukuda H; Yamaguchi T; Masuda G; Negishi M; Ajisawa A; Murata M; Ohnishi K; Irimajiri S; Obana M; Sajima Y; Sagara H; Kato H; Hosoda S; Banba T; Sasaki M; Yoshikawa K; Nakagawa M; Ohkubo H; Kim Y; Akao M; Fukuyama M
    Kansenshogaku Zasshi; 1996 Jul; 70(7):727-45. PubMed ID: 8797308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of clinical efficacy of lomefloxacin (LFLX, NY-198) and pipemidic acid (PPA) in the treatment of infectious enteritis by a double-blind method. The Japan Research Committee of Lomefloxacin Research Group Enteritis].
    Aoki T; Shimizu N; Tomizawa I; Takizawa Y; Matsubara Y; Nitta Y; Sagara H; Seo T; Kanehisa N; Murata M
    Kansenshogaku Zasshi; 1989 Jun; 63(6):606-22. PubMed ID: 2693542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Basic and clinical studies of pazufloxacin on infectious enteritis research group of T-3761 on infectious enteritis].
    Sagara H; Yoshikawa K; Tomizawa I; Takizawa Y; Nitta Y; Tsunoda T; Fukuda H; Yamaguchi T; Masuda G; Negishi M; Ajisawa A; Murata M; Ohnishi K; Irimajiri S; Obana M; Matsumoto F; Imai T; Sakurai I; Takahashi T; Mori M; Mizuno Y; Katoh K; Hosoda S; Bamba T; Saito M
    Kansenshogaku Zasshi; 1996 Jan; 70(1):60-72. PubMed ID: 8822054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Basic and clinical studies of fleroxacin on infectious enteritis. Research Group of AM-833 on infectious enteritis].
    Sagara H; Tomizawa I; Takizawa Y; Nitta Y; Tsunoda T; Yamaguchi T; Masuda G; Negishi M; Ajisawa A; Murata M
    Kansenshogaku Zasshi; 1994 Nov; 68(11):1390-408. PubMed ID: 7829908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [clinical study of balofloxacin on infectious enteritis and assessment of the fecal drug concentration and intestinal microbial flora in patients with inpatients with infectious enteritis. Research group of balofloxacin on infectious enteritis].
    Obana M; Irimajiri S; Tomizawa I; Takizawa Y; Sakamoto Y; Nitta Y; Tsunoda T; Fukuda H; Yamaguchi T; Masuda G
    Kansenshogaku Zasshi; 1995 Sep; 69(9):991-1006. PubMed ID: 7594801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro antibacterial activity of pazufloxacin (PZFX) against clinical isolates from infectious enteritis].
    Fukuyama M; Oonaka K; Hara M; Imagawa Y
    Kansenshogaku Zasshi; 1996 Jan; 70(1):51-9. PubMed ID: 8822053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.
    O'Hare MD; Felmingham D; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1985; 11(4):253-7. PubMed ID: 2941257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro antibacterial activity of balofloxacin (BLFX) against isolates from patients with bacterial enteritis].
    Fukuyama M; Kawakami K; Suda O; Imagawa Y
    Kansenshogaku Zasshi; 1995 Sep; 69(9):987-90. PubMed ID: 7594800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibacterial activity of fosfomycin against the causative bacteria isolated from bacterial enteritis].
    Fukuyama M; Furuhata K; Oonaka K; Hara T; Sunakawa K
    Jpn J Antibiot; 2000 Jul; 53(7):522-31. PubMed ID: 11019386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A clinical experience of rokitamycin on Campylobacter enteritis. Research Group of Rokitamycin on Infectious Enteritis].
    Irimajiri S; Sagara H; Tomizawa I; Takizawa Y; Nitta Y; Seo T; Sato J; Tsunoda T; Ota S; Nakamura Y
    Kansenshogaku Zasshi; 1991 Sep; 65(9):1153-64. PubMed ID: 1761895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical studies on the treatment of Campylobacter enteritis--emergence of quinolone-resistant Campylobacter jejuni after treatment with new quinolones].
    Obana M; Matsuoka Y; Irimajiri S; Tonooka H
    Kansenshogaku Zasshi; 1992 Jul; 66(7):923-9. PubMed ID: 1431368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro antimicrobial activity of DR-3355, a new quinolone antibacterial agent, against clinical isolates of enteritis-causing bacteria].
    Horiuchi S; Inagaki Y; Yamamoto N; Ogawa M; Nakaya R
    Kansenshogaku Zasshi; 1992 Jan; 66(1):51-8. PubMed ID: 1402063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoroquinolones and bacterial enteritis, when and for whom?
    Wiström J; Norrby SR
    J Antimicrob Chemother; 1995 Jul; 36(1):23-39. PubMed ID: 8537271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro antibacterial activity of fleroxacin (FLRX) against clinical isolates from bacterial enteritis].
    Imagawa Y; Fukuyama M; Kawakami K; Suda O
    Kansenshogaku Zasshi; 1994 Nov; 68(11):1409-16. PubMed ID: 7829909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of clinical efficacy of rokitamycin (RKM) and ofloxacin (OFLX) for the treatment of Campylobacter enteritis by a double-blind method. The Research Committee for the Effect of Rokitamycin, Research Group for Infectious Enteritis].
    Obana M; Tomizawa I; Takizawa Y; Nitta Y; Sagara H; Seo T; Sato J; Tsunoda T; Ota S; Machii A
    Kansenshogaku Zasshi; 1991 Sep; 65(9):1165-82. PubMed ID: 1761896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies of lomefloxacin in biliary tract infections].
    Ono Y; Kunii O
    Jpn J Antibiot; 1989 Apr; 42(4):1017-24. PubMed ID: 2769934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and outcome of Shigella, Salmonella and Campylobacter infections in travellers returning from the tropics with fever and diarrhoea.
    Bottieau E; Clerinx J; Vlieghe E; Van Esbroeck M; Jacobs J; Van Gompel A; Van Den Ende J
    Acta Clin Belg; 2011; 66(3):191-5. PubMed ID: 21837926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.